scholarly journals Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization

2015 ◽  
Vol 104 (4) ◽  
pp. 915-920.e1 ◽  
Author(s):  
Ginny Mounce ◽  
Enda McVeigh ◽  
Karen Turner ◽  
Tim J. Child
2017 ◽  
pp. 30-32
Author(s):  
V.Y. Parashchuk ◽  
◽  
A.S. Lutsky ◽  
N.G. Gryshchenko ◽  
◽  
...  

Currently, there is a tendency toward increasing usage of criocycles in programs of in vitro fertilization. This approach allows to achieve pregnancy as well as prevent the development of ovarian hyperstimulation syndrome and utilize the pre-implantation genetic diagnostics. The objective: to improve the efficiency of in vitro fertilization treatment cycles with transferring of cryopreserved/warmed embryos into the uterus. Patients and methods. The study of 824 treatment cycles (in natural menstrual cycle, in cycle with hormone replacement therapy, after egg donation, in natural cycle without embryo transfer in «fresh» cycle, in cycle with hormone replacement therapy without embryo transfer in «fresh» cycle). Vitrification and cryopreservation method. Results. The analysis of the study results has shown that the implantation rate of frozen embryos in the natural cycle is higher than in the cycle with hormone replacement therapy. The implantation rate of frozen embryos after the use of agonist gonadotropin-releasing hormone as a trigger of final maturation of the agonist is higher than that of human chorionic gonadotropin, which allows us to consider vitrification as an effective tool that provides great flexibility of conducting controlled ovarian stimulation cycles and prevention of ovarian hyperstimulation syndrome. Conclusion. The effectiveness of frozen embryo transfer protocols gives us grounds to assert that the optimum cycle for the transfer is a cycle without stimulation. Key words: in vitro fertilization, the endometrium, frozen embryo implantation.


2017 ◽  
Vol 8 (3) ◽  
pp. 101-105
Author(s):  
Kundavi Shankar ◽  
Shipra Nigam ◽  
Thankam R Varma

ABSTRACT Introduction One of the most challenging problems in in vitro fertilization (IVF) is patient with thin endometrium. The objective of the study was to ascertain whether daily human chorionic gonadotropin (hCG) for 7 days with estrogen in hormone replacement frozen embryo transfer (FET) cycles during follicular phase can increase the endometrial thickness (ET) and reduce the cancellation of cycles. Materials and methods Twenty-five infertile patients with resistant thin endometrium who had antagonist protocol and planned for frozen embryo replacement were recruited. These patients had prior attempts to thicken their endometrium which had failed. All the patients received estrogen daily from D2/3 of cycle. On day 8 or 9 of estrogen administration, 200 IU of hCG was given daily for 7 days. After 7 days on hCG priming (D14/15), ET was measured and progesterone was started accordingly. Identification of an intrauterine gestational sac with fetal heart beat by transvaginal ultrasonography constituted clinical pregnancy. Results Mean ET increased significantly from 5.84 to 7.61 mm (p < 0.01). About 72% of patients had more than 20% improvement in their ET after hCG priming. About 76% achieved an ET more than 7 mm. Overall, 50% became pregnant. The ongoing pregnancy rate was 40%. Conclusion A total of 200 IU hCG endometrial priming for 7 days in the proliferative phase of hormone replacement cycles for FET is a highly promising approach to thicken thin endometrium with failed prior attempts. How to cite this article Nigam S, Shankar K, Varma TR. Role of Low-dose Human Chorionic Gonadotropin in Follicular Phase for Thin Endometrium in Frozen Embryo Replacement Cycles in in vitro Fertilization/Intracytoplasmic Sperm Injection Patients: A Pilot Study. Int J Infertil Fetal Med 2017;8(3):101-105.


Sign in / Sign up

Export Citation Format

Share Document